A new study from Université de Montréal and CHU Sainte-Justine Azrieli Research Centre, published in the International ...

February 14, 2025 - IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, yesterday presented ...

NEW YORK - IN8bio, Inc. (Nasdaq: INAB), a biopharmaceutical company specializing in gamma-delta T cell therapies with a current market capitalization of $23.42 million, has announced encouraging Phase ...

More children are surviving cancer because of improved diagnostic methods and targeted treatment, figures from Dutch cancer ...

Improved diagnostics and treatments mean that the survival rate for children with cancer continues to increase, the ...

A new international study has found that a simple tablet treatment could improve survival rates for people with chronic ...

Unrelated cord blood transplant demonstrated efficacy in patients with blood cancer after microcystic adnexal carcinoma.

In children, can being treated for cancer have consequences for the heart—namely, cardiac arrythmias? A new study by ...

Acalabrutinib–Venetoclax improves progression-free survival and reduces disease progression in untreated chronic lymphocytic ...

Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have invented an oral formulation of ...

Acquired miR-142 deficit in leukemic stem cells has been associated with chronic myeloid leukemia blast crisis. Here the authors show that acquired miR-142 deficit in T cells further enables ...